Safety and efficacy of peginterferon Alfa-2a and ribavirin for hepatitis C in thalassemia.

被引：0
|
作者：
Harmatz, Paul
Olivieri, Nancy F.
Kwiatkowski, Janet
Vichinsky, Elliott
Giardina, Patricia
Shah, Farrukh
Wright, Elizabeth C.
Fischer, Roland
Jonas, Maureen M.
机构：
[1] Childrens Hosp, Oakland, CA 94609 USA
[2] Univ Hlth Network, Toronto, ON, Canada
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Cornell Univ, Weill Med Coll, New York, NY USA
[5] UCL, London, England
[6] New England Res Inst, Watertown, MA 02172 USA
[7] Childrens Hosp, Boston, MA 02115 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.558.558
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
558
引用
收藏
页码：168A / 168A
页数：1
相关论文
共 50 条
  • [21] Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C
    Rodriguez-Torres, Maribel
    Jeffers, Lennox J.
    Sheikh, Muhammad Y.
    Rossaro, Lorenzo
    Ankoma-Sey, Victor
    Hamzeh, Fayez M.
    Martin, Paul
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (03): : 257 - 267
  • [22] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [23] Clinical and persistency outcomes in hepatitis C patients treated with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin
    Hassanein, T. I.
    Ye, X.
    Blumentals, W. A.
    Brixner, D. I.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S295 - S296
  • [24] The safety, efficacy and pharmacokinetics of peginterferon alfa-2a (40KD) in children with chronic hepatitis C
    Schwarz, KB
    Mohan, P
    Narkewicz, M
    Molleston, JP
    Te, HS
    Hu, S
    Sheridan, S
    Lamb, M
    Pappas, SC
    Harb, G
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A700 - A700
  • [25] Peginterferon alfa-2a (Pegasys) for chronic hepatitis C
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1151): : 19 - 20
  • [26] Peginterferon alfa-2a in patients with chronic hepatitis C
    Zeuzem, S
    Feinman, SV
    Rasenack, J
    Heathcote, EJ
    Lai, MY
    Gane, E
    O'Grady, J
    Reichen, J
    Diago, M
    Lin, A
    Hoffman, J
    Brunda, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23): : 1666 - 1672
  • [27] Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C Reply
    Rodriguez-Torres, Maribel
    Hamzeh, Fayez
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18): : 1908 - 1908
  • [28] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents
    Sokal, Etienne M.
    Bourgois, Annick
    Stephenne, Xavier
    Silveira, Themis
    Porta, Gilda
    Gardovska, Dace
    Fischler, Bjorn
    Kelly, Deirdre
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 (06) : 827 - 831
  • [29] The cost-effectiveness analysis of combination of peginterferon alfa-2a and ribavirin versus combination of peginterferon alfa-2b and ribavirin in chronic hepatitis C in Poland
    Orlewska, E
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 356 - 356
  • [30] Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
    Ascione, Antonio
    De Luca, Massimo
    Tartaglione, Maria Teresa
    Lampasi, Filippo
    Di Costanzo, Giovan Giuseppe
    Lanza, Alfonso Galeota
    Picciotto, Francesco Paolo
    Marino-Marsilia, Giuseppina
    Fontanella, Luca
    Leandro, Gioacchino
    [J]. GASTROENTEROLOGY, 2010, 138 (01) : 116 - 122
12345